Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita Sajet

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMJ Open Ophthalmology|June 7, 2023
17 Cell viability after DMEK preparationAnita Sajet, Alina Miron, Esther Groeneveld-van Beek, et al.
BMJ Open Ophthalmology|June 7, 2023
24 Effect of graft preparation techniques on clinical outcomes after Descemet membrane endothelial keratoplasty (DMEK)Jessica T Lie, Esther AGroeneveld-van Beek, Silke Oellerich, et al.
BMC Cancer|January 28, 2012
Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancerJ Sven D Mieog, Esther M de Kruijf, Esther Bastiaannet, et al.
Current Eye Research|May 24, 2021
Endothelial Cell Viability after DMEK Graft PreparationAlina Miron, Anita Sajet, Esther A Groeneveld-van Beek, et al.
Molecular Oncology|December 27, 2015
The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysisCharla C Engels, Nienke A de Glas, Anita Sajet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2010
HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patientsEsther M de Kruijf, Anita Sajet, Johanna G H van Nes, et al.
BMC Cancer|August 21, 2014
High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patientsRemco S Derr, Anneke Q van Hoesel, Anne Benard, et al.
BMC Cancer|January 20, 2012
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational studyEsther M de Kruijf, Anita Sajet, Johanna G H van Nes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancerEsther M de Kruijf, Johanna G H van Nes, Anita Sajet, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMJ Open Ophthalmology|June 7, 2023
17 Cell viability after DMEK preparationAnita Sajet, Alina Miron, Esther Groeneveld-van Beek, et al.
BMJ Open Ophthalmology|June 7, 2023
24 Effect of graft preparation techniques on clinical outcomes after Descemet membrane endothelial keratoplasty (DMEK)Jessica T Lie, Esther AGroeneveld-van Beek, Silke Oellerich, et al.
BMC Cancer|January 28, 2012
Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancerJ Sven D Mieog, Esther M de Kruijf, Esther Bastiaannet, et al.
Current Eye Research|May 24, 2021
Endothelial Cell Viability after DMEK Graft PreparationAlina Miron, Anita Sajet, Esther A Groeneveld-van Beek, et al.
Molecular Oncology|December 27, 2015
The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysisCharla C Engels, Nienke A de Glas, Anita Sajet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2010
HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patientsEsther M de Kruijf, Anita Sajet, Johanna G H van Nes, et al.
BMC Cancer|August 21, 2014
High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patientsRemco S Derr, Anneke Q van Hoesel, Anne Benard, et al.
BMC Cancer|January 20, 2012
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational studyEsther M de Kruijf, Anita Sajet, Johanna G H van Nes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancerEsther M de Kruijf, Johanna G H van Nes, Anita Sajet, et al.
Pageof 1